GlassScriptPhysician profile
Laura Weddle
NPI 1093874729
$15,363.95
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13K · 2022: $2,840.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $13,926.51 | 2021-2022 | |
| Abbvie INC. | $428.13 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $383.46 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $209.57 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $135.36 | 2021-2022 | |
| Lundbeck LLC | $114.76 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $68.14 | 2021-2022 | |
| Alkermes, INC. | $54.50 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $28.12 | 2022 | |
| Vanda Pharmaceuticals INC. | $15.40 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Weddle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.